AmplifAI, a Plano, Texas–based AI-powered platform for contact center performance analytics, has raised $33.7 million in Series B funding.
Investors
The round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners.
CVS Health Ventures is a corporate venture capital fund that invests in early- and growth-stage companies aiming to make healthcare more accessible, affordable, and simple. It focuses on innovations in care delivery, whole-person care, consumer-centric health, and disruptive technology. By leveraging CVS Health’s enterprise capabilities, consumer reach, and industry expertise, the fund helps entrepreneurs scale faster and more effectively.
AmplifAI Use of Funds
The company will use the funds to accelerate product development, expand its AI-first approach to contact center transformation, and scale its customer base across industries.
About AmplifAI
Founded in 2018 and led by CEO Sean Minter, AmplifAI is an AI-powered platform for contact center performance analytics that helps organizations optimize their workforce by ensuring agents focus on complex, high-value interactions while AI seamlessly manages simpler contacts. The system integrates customer surveys, voice recordings, chat interactions, and chatbot conversations with performance data to uncover pain points, tailor coaching, and automate workflows. Headquartered in Plano, Texas, AmplifAI serves Fortune 500 and mid-market companies across healthcare, retail, financial services, and technology.
Funding Details
Company: AmplifAI Solutions, Inc.
Raised: $33.7M
Round: Series B
Funding Date: September 2025
Lead Investor: CVS Health Ventures
Additional Investors: LiveOak Ventures, Dallas Venture Partners
Company Website: https://www.amplifai.com/
Software Category: AI Contact Center / Customer Experience Technology
Source: https://www.businesswire.com/news/home/20250923230612/en/